Lista de obras - Richard A. Urbanowicz - Dominio Público Uruguay

A Diverse Panel of Hepatitis C Virus Glycoproteins for Use in Vaccine Research Reveals Extremes of Monoclonal Antibody Neutralization Resistance.

artículo científico publicado en 2015

A next generation vaccine against human rabies based on a single dose of a chimpanzee adenovirus vector serotype C

scientific article published on 15 July 2020

A novel neutralizing human monoclonal antibody broadly abrogates hepatitis C virus infection in vitro and in vivo

artículo científico publicado en 2017

Adjuvant formulated virus-like particles expressing native-like forms of the Lassa virus envelope surface glycoprotein are immunogenic and induce antibodies with broadly neutralizing activity

scientific article published on 04 August 2020

Altered effector function of peripheral cytotoxic cells in COPD.

artículo científico publicado en 2009

An alpaca nanobody inhibits hepatitis C virus entry and cell-to-cell transmission

artículo científico publicado en 2013

An ancestral host defence peptide within human β-defensin 3 recapitulates the antibacterial and antiviral activity of the full-length molecule

artículo científico publicado en 2015

Analysis of serine codon conservation reveals diverse phenotypic constraints on hepatitis C virus glycoprotein evolution

artículo científico publicado en 2014

Antigenicity and Immunogenicity of Differentially Glycosylated Hepatitis C Virus E2 Envelope Proteins Expressed in Mammalian and Insect Cells

artículo científico publicado en 2019

Challenges on the development of a pseudotyping assay for Zika glycoproteins

artículo científico publicado en 2021

Cholesterol conjugation potentiates the antiviral activity of an HIV immunoadhesin

artículo científico publicado en 2015

Cloning and Analysis of Authentic Patient-Derived HCV E1/E2 Glycoproteins

artículo científico publicado en 2019

Differential activation of killer cells in the circulation and the lung: a study of current smoking status and chronic obstructive pulmonary disease (COPD).

artículo científico publicado en 2013

Dramatic potentiation of the antiviral activity of HIV antibodies by cholesterol conjugation

artículo científico publicado en 2014

Enhanced nanoparticle uptake into virus infected cells: Could nanoparticles be useful in antiviral therapy?

scientific article published on 13 June 2018

Evaluation of fresh and cryopreserved hepatocytes as in vitro drug metabolism tools for the prediction of metabolic clearance

artículo científico publicado en 2004

Expression of human ficolin-2 in hepatocytes confers resistance to infection by diverse hepatotropic viruses

scientific article published on 12 February 2019

Flexible and rapid construction of viral chimeras applied to hepatitis C virus.

artículo científico publicado en 2016

Hepatitis C Virus Vaccine: Challenges and Prospects

artículo científico publicado en 2020

Hepatitis C patient-derived glycoproteins exhibit marked differences in susceptibility to serum neutralizing antibodies: genetic subtype defines antigenic but not neutralization serotype.

artículo científico publicado en 2011

Hepatitis C virus quasispecies and pseudotype analysis from acute infection to chronicity in HIV-1 co-infected individuals

artículo científico publicado en 2016

Human Adaptation of Ebola Virus during the West African Outbreak

artículo científico publicado en 2016

Immunization with a synthetic consensus hepatitis C virus E2 glycoprotein ectodomain elicits virus-neutralizing antibodies

artículo científico publicado en 2018

InFusion Cloning for the Generation of Biologically Relevant HCV Chimeric Molecular Clones

artículo científico publicado en 2019

Naturally occurring antibodies that recognize linear epitopes in the amino terminus of the hepatitis C virus E2 protein confer noninterfering, additive neutralization

artículo científico publicado en 2012

Novel functional hepatitis C virus glycoprotein isolates identified using an optimized viral pseudotype entry assay.

artículo científico publicado en 2016

Novel human anti-claudin 1 mAbs inhibit hepatitis C virus infection and may synergize with anti-SRB1 mAb.

artículo científico publicado en 2015

Orthohantaviruses, Emerging Zoonotic Pathogens

artículo científico publicado en 2020

Polymer microarrays rapidly identify competitive adsorbents of virus-like particles

artículo científico publicado en 2020

Quantitative Validation and Comparison of Multiplex Cytokine Kits

artículo científico publicado en 2010

Recombinant human L-ficolin directly neutralizes hepatitis C virus entry.

artículo científico publicado en 2014

Standardized Method for the Study of Antibody Neutralization of HCV Pseudoparticles (HCVpp)

artículo científico publicado en 2019

Structure-based design of hepatitis C virus E2 glycoprotein improves serum binding and cross-neutralization

artículo científico publicado en 2020

Structure-based design of hepatitis C virus E2 glycoprotein improves serum binding and cross-neutralization

artículo científico publicado en 2020

The Relationship of the Mechanisms of the Pathogenesis of Multiple Sclerosis and the Expression of Endogenous Retroviruses

artículo científico publicado en 2020

The role of humoral innate immunity in hepatitis C virus infection.

artículo científico

The role of neutralizing antibodies in hepatitis C virus infection.

artículo científico publicado en 2011

Lista de obras de Richard A. Urbanowicz

A Diverse Panel of Hepatitis C Virus Glycoproteins for Use in Vaccine Research Reveals Extremes of Monoclonal Antibody Neutralization Resistance.

A next generation vaccine against human rabies based on a single dose of a chimpanzee adenovirus vector serotype C

A novel neutralizing human monoclonal antibody broadly abrogates hepatitis C virus infection in vitro and in vivo

Adjuvant formulated virus-like particles expressing native-like forms of the Lassa virus envelope surface glycoprotein are immunogenic and induce antibodies with broadly neutralizing activity

Altered effector function of peripheral cytotoxic cells in COPD.

An alpaca nanobody inhibits hepatitis C virus entry and cell-to-cell transmission

An ancestral host defence peptide within human β-defensin 3 recapitulates the antibacterial and antiviral activity of the full-length molecule

Analysis of serine codon conservation reveals diverse phenotypic constraints on hepatitis C virus glycoprotein evolution

Antigenicity and Immunogenicity of Differentially Glycosylated Hepatitis C Virus E2 Envelope Proteins Expressed in Mammalian and Insect Cells

Challenges on the development of a pseudotyping assay for Zika glycoproteins

Cholesterol conjugation potentiates the antiviral activity of an HIV immunoadhesin

Cloning and Analysis of Authentic Patient-Derived HCV E1/E2 Glycoproteins

Differential activation of killer cells in the circulation and the lung: a study of current smoking status and chronic obstructive pulmonary disease (COPD).

Dramatic potentiation of the antiviral activity of HIV antibodies by cholesterol conjugation

Enhanced nanoparticle uptake into virus infected cells: Could nanoparticles be useful in antiviral therapy?

Evaluation of fresh and cryopreserved hepatocytes as in vitro drug metabolism tools for the prediction of metabolic clearance

Expression of human ficolin-2 in hepatocytes confers resistance to infection by diverse hepatotropic viruses

Flexible and rapid construction of viral chimeras applied to hepatitis C virus.

Hepatitis C Virus Vaccine: Challenges and Prospects

Hepatitis C patient-derived glycoproteins exhibit marked differences in susceptibility to serum neutralizing antibodies: genetic subtype defines antigenic but not neutralization serotype.

Hepatitis C virus quasispecies and pseudotype analysis from acute infection to chronicity in HIV-1 co-infected individuals

Human Adaptation of Ebola Virus during the West African Outbreak

Immunization with a synthetic consensus hepatitis C virus E2 glycoprotein ectodomain elicits virus-neutralizing antibodies

InFusion Cloning for the Generation of Biologically Relevant HCV Chimeric Molecular Clones

Naturally occurring antibodies that recognize linear epitopes in the amino terminus of the hepatitis C virus E2 protein confer noninterfering, additive neutralization

Novel functional hepatitis C virus glycoprotein isolates identified using an optimized viral pseudotype entry assay.

Novel human anti-claudin 1 mAbs inhibit hepatitis C virus infection and may synergize with anti-SRB1 mAb.

Orthohantaviruses, Emerging Zoonotic Pathogens

Polymer microarrays rapidly identify competitive adsorbents of virus-like particles

Quantitative Validation and Comparison of Multiplex Cytokine Kits

Recombinant human L-ficolin directly neutralizes hepatitis C virus entry.

Standardized Method for the Study of Antibody Neutralization of HCV Pseudoparticles (HCVpp)

Structure-based design of hepatitis C virus E2 glycoprotein improves serum binding and cross-neutralization

Structure-based design of hepatitis C virus E2 glycoprotein improves serum binding and cross-neutralization

The Relationship of the Mechanisms of the Pathogenesis of Multiple Sclerosis and the Expression of Endogenous Retroviruses

The role of humoral innate immunity in hepatitis C virus infection.

The role of neutralizing antibodies in hepatitis C virus infection.